See every side of every news story
Published loading...Updated

Theranos founder Elizabeth Holmes loses bid to have appeal of fraud conviction reheard

  • In May 2024, Elizabeth Holmes, the former CEO of Theranos, was denied a rehearing of her 2022 fraud conviction by a federal appeals panel.
  • The denial follows Holmes's conviction for deceiving investors about Theranos's faulty blood-testing technology, with the court declining to have the full panel review the case.
  • Holmes has been serving an 11-year federal prison sentence at a Texas facility since May 30, 2023, and she has been advising her partner Billy Evans on an early-stage biotech startup called Haemanthus.
  • The startup Haemanthus, named for the 'blood flower,' focuses on using Raman spectroscopy and light detection technology to develop AI-guided medical tests for biological materials like sweat and saliva.
  • With appeals exhausted, Holmes's conviction stands and leaves the U.S. Supreme Court as her only remaining option while she expresses intent to resume her biotech career after release.
Insights by Ground AI
Does this summary seem wrong?

15 Articles

All
Left
5
Center
1
Right
2
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources lean Left
63% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States on Thursday, May 8, 2025.
Sources are mostly out of (0)

Similar News Topics